Corient Private Wealth
WST icon

Corient Private Wealth’s West Pharmaceutical WST Stock Holding History

Corient Private Wealth’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.6M Buy
65,759
+6,430
+11% +$1.97M 0.03% 390
2026
Q1 		$14.8M Buy
59,329
+30,979
+109% +$7.71M 0.02% 481
2025
Q4 		$7.8M Buy
28,350
+24
+0.1% +$6.57K 0.01% 625
2025
Q3 		$7.43M Sell
28,326
-22,607
-44% -$5.49M 0.01% 586
2025
Q2 		$11.1M Sell
50,933
-6,498
-11% -$1.39M 0.01% 503
2025
Q1 		$12.9M Sell
57,431
-46,650
-45% -$12.9M 0.02% 466
2024
Q4 		$34.1M Sell
104,081
-2,746
-3% -$864K 0.06% 286
2024
Q3 		$32.1M Buy
106,827
+29,222
+38% +$8.95M 0.05% 324
2024
Q2 		$25.6M Buy
77,605
+13,062
+20% +$4.62M 0.04% 342
2024
Q1 		$25.5M Buy
64,543
+1,284
+2% +$475K 0.05% 342
2023
Q4 		$22.3M Sell
63,259
-210
-0.3% -$74.3K 0.04% 368
2023
Q3 		$23.8M Buy
63,469
+919
+1% +$355K 0.05% 309
2023
Q2 		$23.9M Sell
62,550
-497
-0.8% -$178K 0.06% 306
2023
Q1 		$21.8M Buy
63,047
+60,127
+2,059% +$17.6M 0.06% 285
2022
Q4 		$686K Buy
+2,920
New +$692K ﹤0.01% 1042

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Corient Private Wealth's WST Position: Q2 2026 in Review

Corient Private Wealth increased its West Pharmaceutical (WST) stake by 11% in Q2 2026, buying an estimated $1.97M and bringing the position to 65,759 shares worth $23.6M. The position accounts for 0.03% of the portfolio, ranked #390.

Corient Private Wealth first reported a position in WST in Q4 2022 and has held it in 15 quarters since. The position peaked at $34.1M in Q4 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Corient Private Wealth held 65,759 shares of West Pharmaceutical worth $23.6M as of Q2 2026.
  • Corient Private Wealth bought 6,430 West Pharmaceutical shares in Q2 2026, an estimated $1.97M.
  • West Pharmaceutical made up 0.03% of Corient Private Wealth's portfolio in Q2 2026, its #390 holding.
  • Corient Private Wealth first reported a position in West Pharmaceutical in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's West Pharmaceutical position peaked at $34.1M in Q4 2024.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.